Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study (Q37633813)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study |
scientific article |
Statements
1 reference
Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study (English)
1 reference
Glenwood D Goss
1 reference
Andrew Arnold
1 reference
Frances A Shepherd
1 reference
Mircea Dediu
1 reference
Tudor-Eliade Ciuleanu
1 reference
David Fenton
1 reference
Mauro Zukin
1 reference
David Walde
1 reference
Francis Laberge
1 reference
Mark D Vincent
1 reference
Peter M Ellis
1 reference
Scott A Laurie
1 reference
Keyue Ding
1 reference
Eliot Frymire
1 reference
Isabelle Gauthier
1 reference
Natasha B Leighl
1 reference
Cheryl Ho
1 reference
Jonathan Noble
1 reference
Christopher W Lee
1 reference
Lesley Seymour
1 reference
16 November 2009
1 reference
1 reference
Identifiers
1 reference